http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-101616675-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_457f17bd76b07c818655c6b3992c5df1 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-07 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-724 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-56 |
filingDate | 2007-09-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7410c1638856a2ea7e6b7bb30dcb3727 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9ec6b71ecd6d5c2018100c5bfd9239b1 |
publicationDate | 2009-12-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-101616675-A |
titleOfInvention | The combination medicine of the vitamin A derivative complex that glucocorticoid and beta-schardinger dextrin-are puted together |
abstract | The present invention relates to the combination medicine of the vitamin A derivative complex that glucocorticoid and beta-schardinger dextrin-put together and contain the Pharmaceutical composition of this combination medicine.Available combination medicine of the present invention and compositions reduce or eliminate the skin atrophy that is caused by glucocorticoid (GC) treatment.Also comprise the method that reduces or eliminates the skin atrophy that causes by the GC treatment.In addition, the invention still further relates to the kit that contains the vitamin A derivative complex that glucocorticoid and beta-schardinger dextrin-put together. |
priorityDate | 2006-09-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 354.